Carson Wealth (CWM LLC)
INMB icon

Carson Wealth (CWM LLC)’s INmune Bio INMB Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8K Buy
13,120
+12,002
+1,074% +$17.1K ﹤0.01% 4601
2025
Q4 		$2K Buy
1,118
+457
+69% +$815 ﹤0.01% 5089
2025
Q3 		$1K Buy
661
+208
+46% +$476 ﹤0.01% 5138
2025
Q2 		$1K Sell
453
-105
-19% -$771 ﹤0.01% 5021
2025
Q1 		$4K Buy
558
+276
+98% +$2.19K ﹤0.01% 4543
2024
Q4 		$1K Buy
282
+260
+1,182% +$1.35K ﹤0.01% 4723
2024
Q3 		$0 Buy
+22
New +$156 ﹤0.01% 4970

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carson Wealth (CWM LLC)'s INMB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its INmune Bio (INMB) stake by 1,074% in Q1 2026, buying an estimated $17.1K and bringing the position to 13,120 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4601.

Carson Wealth (CWM LLC) first reported a position in INMB in Q3 2024 and has held it in 7 quarters since. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 13,120 shares of INmune Bio worth $14.8K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 12,002 INmune Bio shares in Q1 2026, an estimated $17.1K.
  • INmune Bio made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4601 holding.
  • Carson Wealth (CWM LLC) first reported a position in INmune Bio in Q3 2024 and has held it in 7 quarters since.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.